Delivery Order SPE2DB20D2014-SPE2DB24FB73L
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $1,118.13 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a prescription insulin product. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025, to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,498.35 firm fixed-price delivery order is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $4,472.64 to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen provides a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,777.36 to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a...
- This $8,272.87 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a branded insulin product. The contract has a completion date of February 15, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S....
- The U.S. Defense Logistics Agency (DLA) awarded a $13,245.96 Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of 4566026495 HUMULIN R 500 UNIT/ML KWIKPEN 3ML. This is not a set-aside contract. The contract has a firm fixed price and an ultimate completion date of October 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of the company's extensive Indefinite Delivery Contract (IDC)...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,490.88 contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a brand name insulin medication. Amerisourcebergen Drug Corp, through its Corporate Office division, serves as the prime contractor on this award. No set-aside designation was used. The...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,590.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The Defense Logistics Agency (DLA) awarded a $3,598.68 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- This federal contract award is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML (a type of insulin medication) to the Defense Logistics Agency (DLA). The $2,236.32 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through February 2024 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB73LDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office Division, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The $4,472.64 Firm Fixed Price contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a type of insulin medication. This Delivery Order does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, the company provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 4/26/24 |